KEMRI, Imperial College London join forces to bring new hope to malaria control 

KENYA – KEMRI and Imperial College London are exploring a potential collaboration on genetic approaches, specifically Gene Drive, to impact malaria control in Kenya significantly. 

This meeting follows the two institutions’ joint grant submissions for research and innovation funding from Horizon 2020 on June 24, 2024.

During the visit, Prof. Christophides George and Prof. Windbichler Nikolai of Imperial College were officially received by Dr. Martin Bundi, the Acting Deputy Director of Research and Development at KEMRI. 

Dr. Bundi, acting instead of Acting Director General Prof. Elijah Songok, emphasized the critical need to leverage advanced technologies to combat malaria in Kenya.

“Malaria is an endemic disease in this country, and there is a need to control it. It is, therefore, important to embrace new technology that can assist in curbing it,” stated Dr. Bundi.

He expressed confidence in Gene Drives and acknowledged the contributions of the entomology and vector control departments. 

Dr. Bundi also highlighted KEMRI’s openness to collaborations that enhance vector control and improve public health.

Prof. Christophides George highlighted the significant progress made by Imperial College in developing genetically modified mosquitoes, which are now ready for field testing in Kenya. 

This progress is a testament to the potential of genetic research in malaria control.

Dr. Damaris Matoke-Muhia, Acting Deputy Director of Biotechnology Programs at KEMRI, mentioned that the institute has ample land suitable for the large-scale field tests required by Gene Drives. 

She also emphasized the potential for the partnership to extend into capacity-building initiatives, including exchange programs and training opportunities for students and scientists at the KEMRI Graduate School (KGS).

Dr. Luna Kamau, Deputy Director of CBRD, Dr. Elizabeth Matei, Dr. Lydia Kibe, and Prof. Charles Mbogo, Chair of PAMCA, attended the meeting. 

This collaborative effort between KEMRI and Imperial College London marks a significant step towards utilizing cutting-edge genetic research to tackle malaria. 

This disease continues to pose a significant public health challenge in Kenya.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE